Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Reusch

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 21, 2013
Influenza vaccination rate among patients with moderate to severe psoriasisMarc Alexander Radtke, Stephan Jeff Rustenbach, Michael Reusch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2011
Skin cancer screening in Germany - perception by the publicMatthias Augustin, Rudolf Stadler, Michael Reusch, et al.
Advances in Therapy|September 15, 2021
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 2, 2021
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)Jonathan Barratt, Branislav Andric, Avtandil Tataradze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2022
Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)Jonathan Barratt, Branislav Andric, Avtandil Tataradze, et al.
The Journal of Dermatology|January 22, 2019
Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumorsWerner Boecker, Michael Reusch, Volker Mielke, et al.
Advances in Therapy|September 19, 2021
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)Botond Csiky, Michael Schömig, Ciro Esposito, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 8, 2013
Allergies in Germany -- prevalence and perception by the publicMatthias Augustin, Nadine Franzke, Florian C Beikert, et al.
Acta Dermato-Venereologica|October 12, 2018
Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation StudyJanine Topp, Matthias Augustin, Kathrin von Usslar, et al.
Dermatology (Basel, Switzerland)|January 9, 2013
Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspectiveThomas Kornek, Ines Schäfer, Michael Reusch, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 21, 2013
Influenza vaccination rate among patients with moderate to severe psoriasisMarc Alexander Radtke, Stephan Jeff Rustenbach, Michael Reusch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 20, 2011
Skin cancer screening in Germany - perception by the publicMatthias Augustin, Rudolf Stadler, Michael Reusch, et al.
Advances in Therapy|September 15, 2021
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 2, 2021
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)Jonathan Barratt, Branislav Andric, Avtandil Tataradze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2022
Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)Jonathan Barratt, Branislav Andric, Avtandil Tataradze, et al.
The Journal of Dermatology|January 22, 2019
Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumorsWerner Boecker, Michael Reusch, Volker Mielke, et al.
Advances in Therapy|September 19, 2021
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)Botond Csiky, Michael Schömig, Ciro Esposito, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 8, 2013
Allergies in Germany -- prevalence and perception by the publicMatthias Augustin, Nadine Franzke, Florian C Beikert, et al.
Acta Dermato-Venereologica|October 12, 2018
Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation StudyJanine Topp, Matthias Augustin, Kathrin von Usslar, et al.
Dermatology (Basel, Switzerland)|January 9, 2013
Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspectiveThomas Kornek, Ines Schäfer, Michael Reusch, et al.
Pageof 5